Stock PAHC PHIBRO ANIMAL HEALTH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Phibro Animal Health Corporation

Equities

PAHC

US71742Q1067

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
17.16 USD +0.23% Intraday chart for Phibro Animal Health Corporation -2.67% +48.19%
May. 09 Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024
May. 08 Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 MT

Evolution of the average Target Price on Phibro Animal Health Corporation

Price target over the last 5 years

History of analyst recommendation changes

a98bcd901ba923125c7dfd20d91344.3bseW5rKGzhRdnq_0IvdoqsZFz-p3VSynO7ZkCEMcTo.lPFOaMOYaFc4DzOPtv-I2t4hY0jmrAHRy6q430RLRVjl0Xsj_I1xWhYpNw~6d421139c8b351ee8a7f19e2ac669518

Analyst Recommendations on Phibro Animal Health Corporation

Morgan Stanley Trims Price Target on Phibro Animal Health to $16 From $17, Maintains Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $17 From $18, Maintains Equal-Weight Rating MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $18 From $19, Maintains Equal-Weight Rating MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $19 From $20, Maintains Equal-Weight Rating MT
Roth Capital Initiates Phibro Animal Health With Buy Rating, Price Target is $18 MT
Morgan Stanley Adjusts Price Target on Phibro Animal Health to $20 From $21, Maintains Equalweight Rating MT
Barclays Adjusts Price Target on Phibro Animal Health to $17 From $22, Reiterates Underweight Rating MT
Morgan Stanley Trims Price Target on Phibro Animal Health to $21 From $23, Keeps Equalweight Rating MT
Barclays Downgrades Phibro Animal Health to Underweight From Equalweight, Price Target at $22 MT
North American Morning Briefing : Inflation, Rate -3- DJ
Barclays Upgrades Phibro Animal Health to Equalweight from Underweight, Keeps $23 Price Target MT
Morgan Stanley Starts Phibro Animal Health at Equal-Weight With $23 Price Target MT
PHIBRO ANIMAL HEALTH : Barclays Downgrades Phibro Animal Health to Underweight From Equal-Weight; Price Target is $23 MT
PHIBRO ANIMAL HEALTH : Morgan Stanley Adjusts Price Target on Phibro Animal Health to $22 From $19, Maintains Underweight Rating MT
PHIBRO ANIMAL HEALTH : Credit Suisse Raises Phibro Animal Health's Price Target to $25 from $23, Keeps Neutral Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
17.16 USD
Average target price
13.5 USD
Spread / Average Target
-21.33%
High Price Target
19 USD
Spread / Highest target
+10.72%
Low Price Target
9 USD
Spread / Lowest Target
-47.55%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Phibro Animal Health Corporation

Morgan Stanley
Roth Capital Partners
Barclays
Credit Suisse

Ratings for Phibro Animal Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PAHC Stock
  4. Consensus Phibro Animal Health Corporation